Zacks Research Upgrades CochLear (OTCMKTS:CHEOY) to “Hold”

CochLear (OTCMKTS:CHEOY) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Separately, UBS Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

CochLear Price Performance

Shares of CochLear stock opened at $39.12 on Monday. The company’s 50-day moving average price is $39.27 and its 200-day moving average price is $64.35. CochLear has a 12-month low of $31.82 and a 12-month high of $105.60.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.